Beranda › Kanker Paru › Idaho › Meridian
Uji klinis Kanker Paru di Meridian, ID
4 studi untuk Kanker Paru mencari peserta di lokasi sekitar Meridian (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
Menerima pesertaFase 3
- Saint Luke's Cancer Institute - Meridian, Meridian
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Idaho Urologic Institute-Meridian, Meridian
- Saint Luke's Cancer Institute - Meridian, Meridian
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Menerima pesertaFase 3
- Saint Luke's Cancer Institute - Meridian, Meridian
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2/3
- Idaho Urologic Institute-Meridian, Meridian
- Saint Luke's Cancer Institute - Meridian, Meridian
Uji klinis Kanker Paru di kota lain
- Houston, TX78 studi
- Boston, MA62 studi
- New York City, NY60 studi
- Los Angeles, CA45 studi
- Arlington, VA41 studi
- Washington, DC41 studi
- Chicago, IL41 studi
- Baltimore, MD40 studi
- Nashville, TN40 studi
- St. Louis, MO39 studi
- Columbus, OH37 studi
- Philadelphia, PA36 studi
Studi lain di Meridian
- Obesitas8 studi
- Kelebihan Berat Badan7 studi
- Kanker Prostat6 studi
- Leukemia Mieloid Akut6 studi
- Aterosklerosis5 studi
- Kanker Paru Non-Sel Kecil4 studi
- Gagal Jantung3 studi
- Kanker Ovarium3 studi
- Karsinoma Sel Skuamosa Kepala dan Leher3 studi
- Eksim3 studi
- Penyakit Kardiovaskular3 studi
- Kanker Kolon3 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.